Literature DB >> 32981108

The probability of the 6-week lockdown in Victoria (commencing 9 July 2020) achieving elimination of community transmission of SARS-CoV-2.

Tony Blakely1, Jason Thompson2, Natalie Carvalho3, Laxman Bablani1, Nick Wilson4, Mark Stevenson2.   

Abstract

Entities:  

Keywords:  COVID-19; Epidemics; Infectious diseases; Models, statistical; Respiratory tract infections

Mesh：

Year:  2020        PMID： 32981108     DOI： 10.5694/mja2.50786

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  13 in total

1.  Association of Simulated COVID-19 Policy Responses for Social Restrictions and Lockdowns With Health-Adjusted Life-Years and Costs in Victoria, Australia.

Authors:  Tony Blakely; Jason Thompson; Laxman Bablani; Patrick Andersen; Driss Ait Ouakrim; Natalie Carvalho; Patrick Abraham; Marie-Anne Boujaoude; Ameera Katar; Edifofon Akpan; Nick Wilson; Mark Stevenson
Journal:  JAMA Health Forum       Date:  2021-07-30

2.  Development of a Computational Policy Model for Comparing the Effect of Compensation Scheme Policies on Recovery After Workplace Injury.

Authors:  Jason Thompson; Camilo Cruz-Gambardella
Journal:  J Occup Rehabil       Date:  2022-05-10

Review 3.  Is the SARS CoV-2 Omicron Variant Deadlier and More Transmissible Than Delta Variant?

Authors:  Bao V Duong; Puchanee Larpruenrudee; Tianxin Fang; Sheikh I Hossain; Suvash C Saha; Yuantong Gu; Mohammad S Islam
Journal:  Int J Environ Res Public Health       Date:  2022-04-11       Impact factor: 4.614

4.  Sexually Transmitted Infection Diagnoses and Access to a Sexual Health Service Before and After the National Lockdown for COVID-19 in Melbourne, Australia.

Authors:  Eric P F Chow; Jane S Hocking; Jason J Ong; Tiffany R Phillips; Christopher K Fairley
Journal:  Open Forum Infect Dis       Date:  2020-11-02       Impact factor: 3.835

5.  Costing of an Australian general practice COVID-19 drive-through testing and respiratory clinic.

Authors:  Patrick Abraham; Jo-Anne Manski-Nankervis; Ruby Biezen; Christine Mary Hallinan; Katherine B Gibney; Lena Sanci; Jemimah Ride
Journal:  BMC Prim Care       Date:  2022-03-29

6.  Simulating Transmission Scenarios of the Delta Variant of SARS-CoV-2 in Australia.

Authors:  Sheryl L Chang; Oliver M Cliff; Cameron Zachreson; Mikhail Prokopenko
Journal:  Front Public Health       Date:  2022-02-24

7.  Basil Hetzel Oration: The COVID-19, racism, mental health and smoking crises.

Authors:  Tom Calma
Journal:  Aust N Z J Public Health       Date:  2022-03-31       Impact factor: 3.755

8.  Estimating age-specific COVID-19 fatality risk and time to death by comparing population diagnosis and death patterns: Australian data.

Authors:  Ian C Marschner
Journal:  BMC Med Res Methodol       Date:  2021-06-21       Impact factor: 4.615

9.  OpenABM-Covid19-An agent-based model for non-pharmaceutical interventions against COVID-19 including contact tracing.

Authors:  Robert Hinch; William J M Probert; Anel Nurtay; Michelle Kendall; Chris Wymant; Matthew Hall; Katrina Lythgoe; Ana Bulas Cruz; Lele Zhao; Andrea Stewart; Luca Ferretti; Daniel Montero; James Warren; Nicole Mather; Matthew Abueg; Neo Wu; Olivier Legat; Katie Bentley; Thomas Mead; Kelvin Van-Vuuren; Dylan Feldner-Busztin; Tommaso Ristori; Anthony Finkelstein; David G Bonsall; Lucie Abeler-Dörner; Christophe Fraser
Journal:  PLoS Comput Biol       Date:  2021-07-12       Impact factor: 4.475

10.  Covasim: An agent-based model of COVID-19 dynamics and interventions.

Authors:  Cliff C Kerr; Robyn M Stuart; Dina Mistry; Romesh G Abeysuriya; Katherine Rosenfeld; Gregory R Hart; Rafael C Núñez; Jamie A Cohen; Prashanth Selvaraj; Brittany Hagedorn; Lauren George; Michał Jastrzębski; Amanda S Izzo; Greer Fowler; Anna Palmer; Dominic Delport; Nick Scott; Sherrie L Kelly; Caroline S Bennette; Bradley G Wagner; Stewart T Chang; Assaf P Oron; Edward A Wenger; Jasmina Panovska-Griffiths; Michael Famulare; Daniel J Klein
Journal:  PLoS Comput Biol       Date:  2021-07-26       Impact factor: 4.475
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.